Trials / Conditions / SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere

SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere

8 registered clinical trials studyying SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere.

Status	Trial	Sponsor	Phase
Unknown	NAC for Attenuation of COVID-19 Symptomatology NCT05074121	Cambridge Health Alliance	Phase 2
Completed	Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety o NCT04629703	Rigel Pharmaceuticals	Phase 3
Completed	Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patien NCT04598594	Assistance Publique - Hôpitaux de Paris	Phase 3
Unknown	Efficacy of Nicotine in Preventing COVID-19 Infection NCT04583410	Assistance Publique - Hôpitaux de Paris	Phase 3
Completed	Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease NCT04419025	Cambridge Health Alliance	Phase 2
Terminated	Cardiovascular Implications of COVID-19 NCT04435457	University of Texas Southwestern Medical Center	—
Terminated	Observational Study of COVID-19 Treatment Efficacy NCT04369989	OSF Healthcare System	—
Withdrawn	A Study of ResCure™ to Treat COVID-19 Infection NCT04395716	ProgenaBiome	Phase 1